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miR-145 suppresses embryo–epithelial juxtacrine communication
at implantation by modulating maternal IGF1R
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ABSTRACT
Successful implantation requires the synchronization of viable
embryonic development with endometrial receptivity. The
mechanisms allowing for the initiation of crosstalk between the
embryo and the endometrium remain elusive; however, recent
studies have revealed that there are alterations in endometrial
microRNAs (miRs) in women suffering repeated implantation failure
and that one of the altered miRs is miR-145. We assessed the role
of miR-145 and its target IGF1R, in early implantation. miR-145
overexpression and IGF1R knockdown were achieved in Ishikawa
endometrial cells. Quantitative PCR, western blotting and 39UTR
luciferase reporter assays confirmed that IGF1R is a direct target of
miR-145 in the endometrium. Attachment of mouse embryos or
IGF1-coated beads to endometrial epithelial cells was used to study
the effects of altered miR-145 and/or IGF1R expression on early
implantation events. miR-145 overexpression or specific reduction
of IGF1R impaired attachment in both cases. An IGF1R target
protector prevented the miR-145-mediated reduction in IGF1R and
reversed the effect of miR-145 overexpression on attachment. The
data demonstrate that miR-145 influences embryo attachment by
reducing the level of IGF1R in endometrium.
KEY WORDS: IGF1R, Endometrium, Implantation, Embryo,
miR-145, miRNA
INTRODUCTION
Implantation failure is a major cause of infertility in the
developed world (Margalioth et al., 2006) and a continuing
problem in assisted reproduction (Ferraretti et al., 2012), where
success rates after IVF still only lie at around 25% and the rate of
embryonic loss at the implantation stage is higher than the rate of
later fetal loss (de los Santos et al., 2003; de Mouzon et al., 2010).
Although definitions of recurrent implantation failure (RIF) vary
(Coughlan et al., 2014; Polanski et al., 2014), it is clear that
embryo transfer commonly leads to a biochemical pregnancy
[human chorionic gonadotropin (hCG) detected but no embryonic
sac] or no detectable pregnancy at all. RIF appears distinct from
recurrent miscarriage; that is, there is a group of women in whom
pregnancy repeatedly fails very early on (Koot et al., 2011). This
might be accounted for by the repeated transfer of karyotypically
abnormal embryos or, alternatively, by a lack of adequate
receptivity in the endometrium.
Prior to the arrival of an embryo, the action of steroid
hormones on endometrium produces a period of receptivity,
referred to as the ‘window of implantation’ (Cha et al., 2012;
Psychoyos, 1974; Tabibzadeh et al., 1987). In humans, this lasts
from approximately day 20 to day 24 of the menstrual cycle
(Achache and Revel, 2006; Aplin, 2000; Aplin and Kimber, 2004;
Bergh and Navot, 1992; Enders, 1989; Psychoyos, 1974). After
the endometrium becomes receptive and the embryo reaches the
blastocyst stage, the embryo must initiate interaction with the
luminal epithelium (Dey, 2004; Nimbkar-Joshi et al., 2009;
Rashid et al., 2011; Tabibzadeh et al., 1987). A cascade of
physiological and molecular events is then triggered, leading to
the establishment of a stable maternal–conceptus relationship
(Garrido-Gomez et al., 2010; Simo´n et al., 2000a; Simo´n et al.,
2000b). It is estimated that half of implantation failures in women
suffering from RIF after embryo transfer are due to defects in
endometrial receptivity. However, little is known about the
molecular events that establish receptivity prior to implantation,
especially in humans (Aplin, 2007), or the mechanisms that
mediate early dialogue between the embryo and endometrium
(Bazer et al., 2009; Cakmak and Taylor, 2011; Salker et al.,
2011).
Analysis of temporal changes in biopsies of endometrial tissue
taken from different stages of the menstrual cycle and from
patients with RIF has been suggested as a means by which to
identify candidate molecules that are involved in mediating
endometrial receptivity. ‘Omics’ technologies have allowed the
identification of candidate mediators of adhesion (Singh and
Aplin, 2014), menstrual-cycle-related alterations and illuminated
adverse effects of some ovarian stimulation regimes (Altma¨e
et al., 2014; Aplin and Singh, 2008; Domı´nguez et al., 2009; Rai
et al., 2010; Vilella et al., 2013), but these have not yet been
exploited in new medical treatments to improve endometrial
receptivity.
MicroRNAs (miRs) suppress gene expression at the
posttranscriptional level by blocking target mRNA translation
or selecting mRNA for degradation (Bartel, 2004). It has been
suggested that they are involved in mediating endometrial
1Maternal and Fetal Health Research Centre, Institute of Human Development,
University of Manchester, Manchester M13 9WL, UK. 2St Mary’s Hospital, Central
Manchester University Hospitals NHS Foundation Trust, Manchester Academic
Health Science Centre, Manchester M13 9WL, UK. 3Nuffield Department of
Obstetrics and Gynaecology, University of Oxford, Level 3, Women’s Centre,
John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK. 4Centre for
Endocrinology & Diabetes, Institute of Human Development, University of
Manchester, AV Hill Building, Oxford Road, Manchester, M13 9PT, UK. 5Faculty of
Life Sciences, Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK.
*Present address: Beth Israel Deaconess Medical Center/Harvard Medical
School, 330 Brookline Avenue, Boston, MA, 02115, USA. `Present address:
Division of Reproduction and Early Development, Leeds Institute of
Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds
LS2 9JT, UK.
§These authors contributed equally to this work
"Authors for correspondence (k.a.forbes@leeds.ac.uk;
john.aplin@manchester.ac.uk)
Received 29 September 2014; Accepted 12 December 2014
 2015. Published by The Company of Biologists Ltd | Journal of Cell Science (2015) 128, 804–814 doi:10.1242/jcs.164004
804
Jo
ur
na
l o
f C
el
l S
ci
en
ce
responses to maternal hormones and regulating the transition
from the proliferative into the secretory phase (Kuokkanen et al.,
2010). Endometrial miRNA profiles are altered in women
suffering from endometriosis – a disease associated with
infertility (Burney et al., 2009; Burney et al., 2007) – and in
patients with RIF (Revel et al., 2011), suggesting that they might
be important regulators of endometrial receptivity and thus
implantation success.
Among the most dysregulated miRs within the endometrium of
women with RIF is miR-145 (Revel et al., 2011). We have
recently shown that miR-145 is important in mediating placental
growth in humans (Farrokhnia et al., 2014; Forbes et al., 2012).
One of the targets of miR-145 is the type-1 insulin-like growth
factor receptor (IGF1R) (La Rocca et al., 2009; Law et al., 2012)
and IGF1R mRNA has been previously shown to be present in
endometrium (Zhou et al., 1994). Despite this, to our knowledge,
its role in regulating human endometrial receptivity or
implantation remains to be explored.
We hypothesized that altered expression of miR-145
contributes to the initial maternal–embryo interaction during the
window of implantation by regulating gene expression in
endometrial epithelial cells. To explore this, we manipulated
miR-145 expression in endometrial cells and assessed embryo
attachment using in vitro models (Kang et al., 2014). We
examined IGF1R as a potential target of miR-145 in epithelium
and the effect of altering the level of the receptor on embryo
attachment. We suggest that IGF1R plays a role in implantation.
RESULTS
miR-145 overexpression prevents embryo attachment
Following transfection with miR-145-specific miR mimics, levels
of miR-145 were significantly increased compared to control
(10–100 nM; P,0.05, n56) (Fig. 1A). The transfection
procedure alone or the presence of a non-targeting miR mimic
had no effect on levels of miR-145. All subsequent experiments
were undertaken using both 50 nM and 100 nM of the mimetic. A
total of 18 5-day-old mouse embryos were transferred to Ishikawa
cells 48 h after transfection with miR-145. The stability of
embryo attachment was measured after a further 24 h of co-
culture (Carver et al., 2003). Displacement or disruption of cells
surrounding the attached mouse embryos, and marked outgrowth
of trophoblast cells were observed in the controls, whereas
embryos attached to miR-145-transfected cells retained the
blastocyst morphology including a clearly defined cavity
(Fig. 1B). Embryo attachment stability was measured using a
five point scale: 1, floating; 2, weakly attached but detached after
tapping; 3, weakly attached but stuck at the attachment site after
tapping; 4, stably attached; and 5, stably attached and showed
outgrowth (Kang et al., 2014). This quantification revealed that
embryos on control cells had attachment scores of 3–5 compared
to scores of 1–2 for miR-145-treated cells. Control cells without
any transfection, and mock or pre-miR transfected cells were
significantly (P50.0097) more stably attached than on miR-145
transfected cells (Fig. 1C).
miR-145 regulates IGF1R expression in Ishikawa cells
miR-145 has multiple targets, one of which is IGF1R, which is
present in the human endometrium (Zhou et al., 1994).
Ishikawa cells were transfected with a miR-145 mimic and
the effect on IGF1R mRNA and protein monitored using
quantitative real-time PCR (QPCR) and western blotting,
respectively. Despite no changes in IGF1R mRNA (Fig. 2A),
IGF1R protein expression was reduced 48 h following miR-145
overexpression (Fig. 2B).
To determine whether miR-145 directly binds to IGF1R
in these cells, the highly conserved predicted binding site
within the IGF1R 39UTR (3804–3810 bp) was cloned into the
Fig. 1. See next page for legend.
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pmiR-GLO luciferase reported vector alone or in combination
with miR-145 mimics (Fig. 2C). As expected, luciferase
activity was detected under all conditions in the presence
of a non-targeting mimic. In the presence of the miR-145
mimic there was an 81% reduction in luciferase activity of the
IGF1R 3804–3810 vector (Fig. 2C; P50.0079, n55). Co-
transfection of the miR-145 mimic with the empty pmiR-GLO
(empty vector) or the scrambled IGF1R 39UTR vector (IGF1R
D3804–3810) did not alter luciferase activity. This indicates
that miR-145 binds directly to the 3804–3810 region in IGF1R
39UTR.
Fig. 1. miR-145 regulates embryo attachment. Ishikawa cells were mock-
transfected (mock) or transfected with a non-targeting control miR-mimic
(control mimic) or a miR-145 mimic (10–100 nM). (A) Overexpression of miR-
145 was confirmed by QPCR. ***P,0.0001 (n56, Wilcoxon Signed Rank
test in comparison to control). The box represents the 25–75th percentiles,
and the median is indicated. The whiskers show the range. (B) Phase-
contrast images at three z-planes of mouse embryos attached to Ishikawa
endometrial cells following transfection with miR-mimics. Images were taken
after 24 h of co-culture (representative of n515). (C) The stability of
mouse embryo attachment to Ishikawa cells was assessed as previously
described (Kang et al., 2014). Data are expressed as median and
interquartile range. **P,0.01 (n53, Kruskal–Wallis test with Dunn’s
multiple comparison).
Fig. 2. miR-145 regulates IGF1R
expression. (A,B) Ishikawa cells
were transfected with a non-targeting
(control mimic) or miR-145 specific
miR mimic (10–100 nM) and
appropriate controls. (A) IGF1R
mRNA expression was quantified by
QPCR and normalized to b-actin
mRNA. Data are presented as a fold
change in comparison to control
(n56). There is no observed change
in mRNA expression. (B) Western
blotting revealed decreased
expression of IGF1R protein following
transfection with miR-145 mimic at
100 nM in comparison to control.
Blots were stripped and re-probed
with anti-GAPDH antibodies to
correct for protein loading. Blots
represent at least three individual
sample sets. Data are expressed as
median and interquartile range.
(C) Synthetic oligonucleotides for the
specific (IGF1R 3804–3810) or
mutated (IGF1R D3804–3810) miR-
145-binding sites in IGF1R mRNA,
were cloned in to pmiR-GLO
luciferase reporter vector and
transfected in to Ishikawa cells in the
presence of non-targeting (control
mimic) or miR-145 specific miR-
mimics. Direct interaction between
miR-145 and IGF1R in Ishikawa cells
was assessed by luciferase reporter
assay. Levels of firefly luciferase were
assessed and normalized to levels of
b-galactosidase. *P,0.05 (n55,
Kruskal–Wallis test). For A and C, the
box represents the 25–75th
percentiles, and the median is
indicated. The whiskers show the
range.
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 804–814 doi:10.1242/jcs.164004
806
Jo
ur
na
l o
f C
el
l S
ci
en
ce
IGF1R is upregulated in the endometrial epithelium at the
time of endometrial receptivity
Previous studies have localized IGF1R mRNA in vivo to
endometrial luminal and glandular epithelium (Zhou et al.,
1994) but localization of IGF1R protein has not been reported.
We examined IGF1R protein expression in human endometrium
at different time points in the menstrual cycle (proliferative, days
7–17; early secretory, days 18–20; mid-secretory, days 20–21;
late secretory, days 26–27). IGF1R was detectable at all stages
(Fig. 3A,C,E,G). Some regional variation in epithelial staining
was evident, but staining intensity was highest at the endometrial
luminal epithelium during the mid and late secretory stages
(Fig. 3E,G).
miR-145 overexpression prevents IGF1-loaded
bead attachment
Multiple factors are released from embryos and/or are present
in the uterine fluid, including the predominant ligand for
IGF1R, IGF1 (Kane et al., 1997). To demonstrate functional
receptor at the apical epithelial surface, and to assess the
possibility that IGF1R might contribute directly to an adhesive
interaction at the cell surface, we examined attachment to
confluent Ishikawa cells of IGF1-coated embryo-sized beads
(Kang et al., 2014). Attachment of beads was assessed by
counting the number stably attached against the total number of
beads originally transferred (Kang et al., 2014). Following
overexpression of miR-145 (48 h), IGF1 or BSA (negative
control)-loaded beads were transferred and, 24 h later,
attachment was assessed. 52% of beads carrying IGF1 were
stably attached under control conditions (Fig. 4) and following
miR-145 overexpression this was reduced to 17% (100 nM;
P,0.01; n55). Levels of attachment were unaffected by the
transfection procedure (mock) or in the presence of non-
targeting miR (control mimic). Levels of attachment of BSA-
coated beads were low and unaffected by miR-145
overexpression.
Fig. 3. IGF1R is present in endometrial luminal
epithelium at the receptive phase. Endometrial biopsies
obtained from different stages of the menstrual cycle were
stained for IGF1R. Mouse IgG was included as a negative
control in adjacent sections. IGF1R is expressed in the
endometrium throughout the menstrual cycle but appears to
be primarily localized to the endometrial epithelium (arrows)
in the mid-late secretory stages, the former representing the
time of optimal endometrial receptivity. Insets in A and E
show luminal epithelium at higher magnification. Each
image is representative of at least three tissue samples.
Scale bar: 75 mm. Insets are 75 mm across.
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siRNA-mediated knockdown of IGF1R suppresses embryo
attachment
The role of IGF1R in mediating embryo attachment was
examined using small interfering RNA (siRNA) (100 nM) to
directly reduce its expression in endometrial cells. Western
blotting confirmed IGF1R expression to be reduced by 80% after
48 h (Fig. 5A,B). Attachment of mouse embryos (Fig. 5C,D) or
IGF1-coated beads (Fig. 5E) was reduced following IGF1R
knockdown (P,0.05). To determine whether the effect of miR-
145 on attachment is mediated by its ability to target IGF1R, we
prevented the interaction of miR-145 with the IGF1R 39UTR
using the specific miR-target protector for the 3804–3810 region
of IGF1R mRNA (Fig. 5F,G). miR-145 mimics (50 nM)
significantly reduced IGF1R protein (Fig. 5F) and attachment
of IGF1-coated beads (Fig. 5G) compared to non-targeting miR
mimics (control mimic). Western blotting (Fig. 5F) demonstrated
that miR-145 was unable to reduce levels of IGF1R in the
presence of the target site-specific target protector (IGF1R TP
3804–3810). The ability of miR-145 to reduce attachment of IGF-
I-loaded beads was significantly attenuated in the presence of the
target-site-specific target protector (IGF1R TP 3804–3810;
100 nM; P,0.05) but was unaffected by the scrambled IGF1R
target protector (D3804–3810; 100 nM) (Fig. 5G). This suggests
that the effects of miR-145 on embryo attachment are directly
mediated by IGF1R.
DISCUSSION
Array approaches are cataloguing biomarkers of receptivity,
comparing endometrium from different stages of the menstrual
cycle or from fertile and infertile women (Altma¨e et al., 2010;
Ruan et al., 2013), but data are difficult to interpret in the absence
of functional information on the role of putative markers in
the process of implantation. Comparison of miR profiles of
endometrium from RIF and normally fertile women yielded a
group of candidates among which miR-145 showed an
,threefold elevation (Revel et al., 2011), leading to a
hypothesis that among its targets are components vital for
implantation. However, the cell populations expressing miR-145
were not identified. By using an embryo attachment model, we
now demonstrate that overexpresssion of miR-145 at levels
approximately comparable to those reported in RIF endometrium
reduces the stability of the embryo–epithelial interaction. Given
the barriers to direct examination of human embryo implantation,
in vitro modelling is a viable approach to gathering relevant
functional information to complement the analytical data
emerging from arrays. Translated to the in vivo situation, we
predict that such an effect might delay implantation to the point
where corpus luteum rescue would not occur, leading to a failed
pregnancy. Data from the rat similarly point to a role for miRs in
regulating endometrial cell function in the implantation window
(Xia et al., 2014a; Xia et al., 2014b). Such a prediction in human
must be tempered by the limitations of the in vitro model, which
includes the use of mouse embryos and cells from a well-
differentiated adenocarcinoma. However, a recent proteomics
study of apically displayed glycoproteins in polarized Ishikawa
cells showed that these were substantially similar to the
epithelium in vivo (Singh and Aplin, 2014). Furthermore we
have observed that hatched human blastocysts attach to these
cells with kinetics that are not dissimilar to those of the mouse
(unpublished).
Following previous reports that IGF1R is a target gene for
miR-145 (La Rocca et al., 2009; Law et al., 2012), we have
shown that overexpression of miR-145 reduces the level of
IGF1R protein in endometrial epithelial cells, and identified a
target site in the 39UTR. This is consistent with miR action in
mammalian cells through translational repression (Erson and
Petty, 2008). A previous study reported mRNA encoding IGF1R
in the endometrial luminal epithelium during the mid-late
secretory phase (Zhou et al., 1994). We have here extended
these data to show the distribution of the protein through the
normal cycle and, most importantly, its expression in mid
secretory luminal epithelium. Direct evidence for hormonal
control of IGF1R expression comes from studies in isolated
human endometrial cells that report IGF1R downregulation by
progesterone (Strowitzki et al., 1996). In rats, IGF1R expression
in the uterus is enhanced by estrogen treatment (Ghahary and
Murphy, 1989) and in baboons, expression at the glandular and
luminal epithelium undergoes cyclic changes and is upregulated
by estrogen (Hild-Petito et al., 1994).
Our data reveal that there might be a previously unsuspected
role for IGF1R in regulating embryo attachment, with stability of
adhesion to the epithelium dropping after receptor knockdown in
a fashion that parallels the effect of miR-145 overexpression.
IGF1R is a protein tyrosine kinase that is predominantly activated
by IGF1 and IGF2. Immunoblotting identified IGF1R as being
expressed in Ishikawa cells, so we adopted a ligand-coated bead
assay (Kang et al., 2014) to probe its presence and function at the
apical epithelial surface where embryo attachment is initiated.
The observations that IGF1-coated beads can attach stably and
that IGF1R knockdown impairs this process, might indicate the
presence of receptor at the apical cell surface and, perhaps
surprisingly, its ability to mediate an adhesive interaction with an
object that approximates the size of the implanting blastocyst. By
specifically inhibiting the interaction between miR-145 and
IGF1R 39UTR, without affecting interaction between miR-145
and other targets, we were further able to attribute the effects of
miR-145 on embryo attachment to interaction with IGF1R.
Previous work in receptive-phase mouse uterus has shown that
IGF1 delivered on the surface of a bead could activate a response
in the epithelium that was transduced to stroma to influence
Fig. 4. miR-145 overexpression reduces IGF1-coated bead attachment.
Ishikawa cells were mock-transfected, transfected with a non-targeting
control miR-mimic or a miR-145 mimic (10–100 nM) and cultured for 48 h
prior to transfer of beads coated in IGF1 (IGF-I) or BSA (negative control).
Attachment was assessed after a further 48 h using a scale adapted
from Kang et al., 2014. Data are expressed as a percentage of total
beads. The box represents the 25–75th percentiles, and the median is
indicated. The whiskers show the range. **P,0.01 (n55, Kruskal–Wallis
test).
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vascular permeability (Paria et al., 2001). Our data further
validate the ligand-coated bead interaction model as a tool
to investigate expression and function of apical epithelial
receptors.
Although IGF2 is expressed by both the mouse and human
blastocyst (Lighten et al., 1997; Szabo´ and Mann, 1995), there
is no evidence at present that surface-associated IGFs are
displayed on trophectoderm. IGF ligands, however, are produced
Fig. 5. See next page for legend.
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endogenously in the endometrium (Giudice et al., 1993;
Murphy and Ghahary, 1990). One hypothesis consistent with
these data is that IGF2 released by the implanting embryo
activates IGF1R locally in epithelial cells, and signals ensue
through the phosphoinositide 3-kinase (PI3K) and mitogen-
activated protein kinase (MAPK) pathways to influence
downstream factors regulating attachment (Forbes and
Westwood, 2008; Forbes et al., 2008). For example, in breast
cancer cells IGF1R activation upregulates fascin-1, a modulator
of adhesion and cell–cell interactions (Wong et al., 1999) to
promote reorganization of cell–cell contacts (Guvakova et al.,
2002a; Guvakova et al., 2002b; Yamashiro et al., 1998).
Increased expression of fascin has been reported at implantation
sites in mice, suggesting that it has a potential role in the initial
adhesion stages (Yoon et al., 2004).
However, in recent years it has emerged that binding and
crosstalk between IGF1R and cell–cell or cell–matrix adhesion
molecules can occur in either the presence or absence of IGF
ligand, including with integrin avb3 (Maile et al., 2008; Xi et al.,
2008), which is involved in implantation (Kang et al., 2014;
Lessey, 1997). Such interactions are important for cytoskeletal
organization, cell adhesion and motility (Andre´ et al., 1999;
Clemmons and Maile, 2005; Juliano and Haskill, 1993; Mauro
and Surmacz, 2004; Tai et al., 2003). Further work is therefore
required to examine the possibility that cis interactions between
growth factor receptors and adhesion molecules might occur at
the apical luminal epithelial plasma membrane during
implantation.
miRs alter the expression of target genes in one of two ways
depending on the level of base complementarity with the 39UTR
of the target mRNA. Complete complementarity results in
degradation of target, whereas partial complementarity induces
translational repression (Filipowicz et al., 2008). Partial
complementarity enables miRs to regulate expression of
multiple targets (Erson and Petty, 2008), and despite our miR-
145 target blocking data demonstrating that IGF1R mediates the
effects of miR-145 on embryo attachment, we cannot rule out that
miR-145 has effects on implantation by targeting genes other than
IGF1R. For example, miR-145 targets MUC-1 in the human
embryonic kidney cell line HEK293 (Sachdeva and Mo, 2010);
MUC-1 is expressed on the luminal epithelium of the
endometrium (Hey et al., 1994) and is cleared at the site of
implantation as a result of local juxtacrine signaling of the
embryo (Singh et al., 2010). In both Ishikawa cells and primary
endometrial cells, miR-145 regulates the expression of fascin
(Adammek et al., 2013; Go¨tte et al., 2010).
miR-145 is a regulator of endometrial IGF1R expression, and
our in vitro model has suggested that IGF1R has a role in
implantation. IGF1R is upregulated at the time of embryo
attachment in vivo and reduced expression in epithelial cells
destabilizes embryo attachment in vitro. Reduced IGF1R
expression has been reported in mid-secretory endometrium in
women with unexplained infertility (Wu and Zhou, 2004). There
is evidence for regulation by leukemia inhibitory factor (LIF),
which is required for endometrial receptivity in mice (Rosario
et al., 2014). miR-145 in endometrium might be sensitive to
steroid hormone – whereas estrogen influences expression in
mouse splenic lymphocytes (Dai et al., 2008), it is under the
control of progesterone in murine endometrial epithelial cells
(Yuan et al., 2014). We have yet to establish whether miR-145 is
under hormonal control in the human endometrium, but future
studies will explore the possibility of utilizing synthetic steroids
to modulate expression. We note the therapeutic potential of
targeted miR-145 inhibitors (Caruso et al., 2012) and suggest that
therapies to suppress miR-145 in the endometrium might improve
pregnancy rates in women with RIF.
MATERIALS AND METHODS
Endometrial tissue
Endometrial biopsies were from pre-menopausal women at different points in
the menstrual cycle were obtained anonymously from local pathology
archives. Research access to the pathological archive of St Mary’s Hospital
was approved by Central Manchester REC. No signs of hyperplasia, neoplasia
or inflammation were present in these samples. Dating of the menstrual cycle
was established from histopathology reports and was confirmed by
histological examination of sections stained with haematoxylin and eosin.
Cell culture
Ishikawa cells (a well-differentiated human endometrial adenocarcinoma
line), obtained from American Type Cell Culture (ATCC), were
maintained in phenol red-free DMEM/F12 medium (Invitrogen, UK)
supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 mg/
ml streptomycin and 2 mM L-glutamine. Cells were grown in 95% air
and 5% CO2 on matrigel (1:8 dilution; growth factor-reduced, BD, UK)
for further attachment assays.
Animals, superovulation and embryo recovery
All experiments were conducted under a Home Office license and the
Animal Act, 1986, and had local ethical approval for care and use of
laboratory animals. C57BL/6 strain mice were maintained by the
Biomedical Services Unit at the University of Manchester. Mice were
kept under standard environmental conditions of 12 h light and 12 h dark
and housed at 20–22 C˚ and 40–60% humidity with food and water
provided at ad libitum and males (less than 6 months old) were caged
singly. Female mice (6–8 weeks) were superovulated with 5 IU of
pregnant mare serum gonadotrophin (PMSG, Calbiochem, Nottingham,
UK) and ovulation was synchronized by 5 IU human chorionic
gonadotrophin (hCG, Intervert UK, Milton Keynes, UK) 46–48 h later,
both by intraperitoneal injection. Females were placed singly with males
Fig. 5. The effects of miR-145 on embryo attachment are mediated by
IGF1R. Non-targeting (NT) or IGF1R-specific siRNA (100 nM) were
transfected into Ishikawa cells. Untreated (‘C’) and mock-transfected cells
were included as controls. (A) Knockdown was confirmed by western
blotting. Membranes were re-probed for b-actin to control for protein loading.
(B) Density of bands was quantified, and levels were normalized to b-actin
and expressed as a fold change relative to control. *P,0.05, **P,0.01 (n53,
one-way ANOVA with Tukey’s multiple comparison test). Data are expressed
as median and interquartile range. (C–E) Cells transfected with IGF1R
siRNA or appropriate controls (NT siRNA) were used for in vitro implantation
using (C–D) mouse embryos or (E) ligand-coated beads [IGF1 (IGF-I) or
BSA]. (C) Phase-contrast images of mouse embryos attached to Ishikawa
cells after knockdown of IGF1R at three z-plane levels, taken 24 h after
transfer of embryos (n515). (D) The stability of mouse embryo attachment to
Ishikawa cells following transfection with IGF1R siRNA. ***P,0.001 (n56,
Kruskal–Wallis with Dunn’s multiple comparison). (E) The effect of IGF1R
knockdown on firm attachment of IGF1-coated beads was monitored. IGF1R
knockdown resulted in a reduction in IGF1-coated bead attachment in
comparison to controls **P,0.01 (n55, Kruskal–Wallis test).
(F–G) Ishikawa cells were transfected with a specific miR target protector
(TP) (100 nM) for the miR-145-binding site at the 3804–3810 bp region of
IGF1R 39UTR (IGF1R TP 3804–3810) or with a scrambled sequence for this
region (IGF1R TP D3804–3810), which served as a negative control in the
presence of a non-targeting control mimic (control mimic) or miR-145 specific
miR mimic (miR-145 mimic). (F) Western blotting confirmed that the IGF1R
39UTR IGF1R target protector (3804–3810) prevented miR-145 induced
reduction in IGF1R protein expression after 48 h. (G) Analysis of stable
attachment of IGF1-coated beads was assessed after a subsequent 48 h.
BSA-coated beads were included as a control. * P,0.05 (n55, Kruskal–
Wallis test). For D,E,G, the box represents the 25–75th percentiles, and the
median is indicated. The whiskers show the range.
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 804–814 doi:10.1242/jcs.164004
810
Jo
ur
na
l o
f C
el
l S
ci
en
ce
of the same strain overnight. The presence of a vaginal plug the following
morning (day 1 of pregnancy) was used as an indicator of successful
mating. Pregnant mice were killed on day 2, 48 h after hCG injection.
Using sterilized scissors and forceps the lower abdominal cavity was
incised and both oviducts dissected. Two-cell embryos were obtained
from the oviduct either by flushing using a 34G blunt-ended stainless
steel needle (Cooper Needleworks, Birmingham, UK) and syringe.
Flushed embryos were washed with M2 media (Sigma) supplemented
with 4 mg/ml BSA washed in KSOM (Millipore, UK) and cultured in a
30 ml drop of KSOM covered with mineral oil at 5% CO2, 37 C˚ until the
blastocyst stage. Only expanded blastocysts with clearly observable inner
cell mass and trophectoderm on day 5 were included in the study.
IGF1R localization
Sections of endometrial tissue (5 mm thick), or Ishikawa cells fixed in
4% PFA were incubated overnight at 4 C˚ in a humidity chamber, with
either rabbit polyclonal anti-IGF1R antibody (1:75; Cell Signaling
Technologies, 3027) or IgG purified from rabbit serum (1:2000; Cell
Signaling Technologies) followed by anti-rabbit biotinylated antibody
(1:200) (Dako), avidin peroxidase and then developed by DAB as
previously described (Forbes et al., 2008).
Overexpression of hsa-miR-145 in Ishikawa cells
Non-targeting (Cy3-labeled Pre-miR precursor negative control) or miR-
145 specific miR mimics (Pre-miR mimics; Ambion, UK) were
transfected into Ishikawa cells (10–100 nM) with DharmaFECT2
reagent (Dharmacon, UK) as previously described (Kang et al., 2014).
Following transfection, cells were cultured for up to 96 h in 20% O2 at
37 C˚. Prior to analysis in subsequent experiments, overexpression was
confirmed by QPCR. The effect of miR-145 overexpression was
compared with that of three controls: untreated cells, tissue exposed to
transfection procedure alone (mock) or tissue transfected with non-
targeting miR mimic (Pre-miR precursor negative control, Ambion, UK)
which has no known homology to any mammalian miRs.
siRNA mediated knockdown of IGF1R
siRNA sequences used to target the human IGF1R gene (GenBank NM-
000875) were either in a SMARTPool containing four different target
sequences: A, 59-GGAAGCACCCUUUAAGAAU-39; B, 59-GGACUC-
AGUACGCCGUUUA-39; C, 59-AAAUACGGAUCACAAGUUG-39 and
D, 59-AGUGAGAUCUUGUACAUUC-39 (100–500 nM; Dharmacon,
UK), or using a single validated sequence 59-GGAAUACAGGAA-
GUAUGGA-39 (100–500 nM; Ambion, UK). Silencer Select Negative
Control siRNA (Ambion, UK), which does not target any known sequence
in the human genome, was used in control experiments. The specific and
non-targeting siRNA sequences were transfected into Ishikawa cells using
DharmaFECT 2 reagent as previously described (Kang et al., 2014).
Quantitative RT-PCR based analysis of miR expression
Total RNA was extracted from Ishikawa cells from at least six separate
experiments by using the miRVANA total RNA extraction kit (Ambion,
UK) and quantified using a Quant-iT Ribogreen kit (Molecular Probes).
The expression of miRs was assessed using the miRCURY LNATM
Universal RT microRNA PCR system (Exiqon) following the
manufacturer’s instructions. Briefly, 25 ng RNA was reversed
transcribed using Universal cDNA Synthesis kit (Exiqon), which
allows polyadenylation and reverse transcription of all miRs within the
sample into cDNA in a single reaction step. Individual miRs were then
detected using LNA-enhanced miRNA-specific primer sets (Exiqon) for
hsa-miR-145 (target sequence: 59-GUCCAGUUUUCCCAGGAAUC-
CCU-39) or 5S rRNA. miR expression was quantified against standard
curves generated from human reference total RNA (Stratagene, USA).
PCRs were performed in duplicate for each sample to control for user
error, using a Stratagene MX3000P real-time PCR machine. Values were
only deemed acceptable when each replicate sample deviated by less than
1 from its matched duplicate. The CT value for each sample (i.e. the
average of the two duplicates) was used to calculate absolute values
(determined from the standard curve). To further control for variations in
sample input into the PCR assay, levels of miR-145 were normalized to
5S rRNA, which is present at equal levels in all our samples (data not
shown). Data were then expressed as fold change compared to control
and analysed using the Wilcoxon signed-rank test.
Quantitative RT-PCR based analysis of mRNA expression
Total RNA was extracted from Ishikawa cells by using the miRVANA
total RNA extraction kit (Ambion UK) and quantified using a Quant-iT
Ribogreen kit (Molecular Probes). 100 ng of total RNA from each
sample was reverse transcribed using AffinityScript cDNA synthesis
kit (Stratagene, USA) and IGF1R and b-actin mRNA was amplified
by QPCR using 200 nM primers 55 C˚ [IGF1R: forward, 59-
GAAGGAGGAGGCTGAATAC-39; reverse, 59- CTACAACATCAC-
CGACC-39; Invitrogen (Paisley, UK); b-actin: forward, 59-
AGCCACCCCACTTCTCTCTAA-39, reverse, 59-ACACGAAAGCA-
ATGCTATCACCT-39 (MWG Biotech, UK)] and Stratagene Brilliant
SYBR Green II QPCR mastermix, with 5-carboxy-x-rhodamine as a
passive reference dye in a Stratagene’s MX3000P real time PCR
machine. mRNA expression was quantified against standard curves
generated from human reference total RNA (Stratagene, USA). Data
were normalized to b-actin mRNA then expressed as a percentage of
levels measured in cells transfected with pre-miR negative control mimic,
and analysed using the Wilcoxon signed-rank test.
In vitro implantation models
Embryo attachment assay
Mouse embryos (5 days old) were transferred onto Ishikawa cells in
independent microwells of a 96-well plate. Multiple observations of
attaching embryos from 24–48 h after transfer allowed distinct stages of
attachment to be identified. A standardized plate movement protocol was
implemented to characterize the stability of attachment: the plate was moved
quickly three times laterally and then orthogonally to detect unattached
embryos. Upon moving the plate, unattached embryos floated, or rolled, over
the epithelial surface. Attached embryos were then examined for tandem
movement when the microscope stage was tapped. At initial attachment,
embryo wobble was observed, whereas at more advanced stages of
attachment, embryos moved fully in concert with the underlying epithelial
layer. Five stages of attachment were defined and used as a measurement
scale as previously described (Carver et al., 2003; Kang et al., 2014).
Bead attachment assay
10 ml of embryo-sized beads (Bio-Rad) were washed six times in sterile
PBS. Beads were then incubated with 20 ml of 100 ng/ml IGF1 (R&D)
and BSA (RIA Grade, Cat no: A7888, Sigma) dissolved in PBS, and
overlaid with 1 ml of mineral oil (Sigma) at 37 C˚ for 2 h. Beads were
used immediately after incubation. Prior to co-culture, the mineral oil
was removed and the beads were washed in sterile PBS to remove any
unbound growth factor. Beads were then re-suspended in sterile PBS and
10–15 beads bearing IGF1 or BSA were transferred onto each well of
Ishikawa cells in 96-well plate as previously described (Kang et al.,
2014). After 24–48 h of co-culture, cells containing beads were washed
with PBS and fixed with 4% PFA. The number of attached beads was
counted and analysed by normalizing to the total number of beads
transferred.
Western blotting
Following appropriate experimental treatment, cells were washed in PBS
and scraped into RIPA buffer. 30 mg of protein was loaded into each well
of 8% SDS-polyacrylamide gels and protein was separated
electrophoretically by molecular mass. The separated proteins were
then transferred onto PVDF membrane (Millipore) and blocked with 5%
BSA in TBS with Tween-20 at room temperature for 1.5 h. Membranes
were then probed with rabbit anti-phospho-IGF1R antibody (1:1000;
Product number 3027; Cell Signaling Technologies), or a rabbit antibody
against the b subunit of IGF1R (C20; 2 mg/ml; Santa Cruz Biotech) at
4 C˚ overnight, washed with TBS with Tween-20, and incubated with
horseradish peroxidase (HRP)-conjugated anti-rabbit-IgG antibody at
room temperature for 1 h. The protein was exposed to the enhanced
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 804–814 doi:10.1242/jcs.164004
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chemiluminescence system (Amersham) and then to Amersham or Kodak
hyperfilm. Blots were stripped and reprobed with mouse-anti-b-actin
(4.5 mg/ml; Sigma) or rabbit anti-GAPDH (1:1000; Cell Signaling
Technologies) antibodies to control for protein loading. ImageJ (National
Institute of Health, Bethesda, MD) was used to quantify bands comparing
to loading control.
Assessment of miR-145–IGF1R interaction
pmiR-GLO Dual-Luciferase miRNA Target Expression Vector
(Promega) was used to demonstrate the interaction between miR-145
and IGF1R. The 39 untranslated region (UTR) of IGF1R was cloned into
the multiple cloning site (MCS) in the 39UTR of the firefly luciferase
gene. The principle of the vector is such that if endogenous miRs bind to
the 39UTR following introduction into cells, translation of firefly
luciferase will be reduced.
IGF1R 39UTR luciferase reporter constructs
Two 42 base pair (bp) oligonucleotides and complementary antisense
strands were designed using TargetScan (http://www.targetscan.org) to
correspond to the highly conserved region of the IGF1R 39UTR to which
miR-145 is predicted to bind (3804–3810 bp; supplementary material
Table S1). Pme1 and Xba1 overhangs were incorporated to ensure correct
orientation of the oligonucleotide from 59 to 39. A Not1 restriction site
was included, to act as an internal restriction site to confirm successful
ligation. A scrambled version of the first predicted binding site was
included as a control (supplementary material Table S1).
Prior to ligation, the pmiR-GLO Dual-Luciferase miRNA Target
Expression vector was linearized with Pme1 (New England Bio Labs)
and Xba1 (Roche) restriction enzymes to ensure complementarity with
oligonucleotide overhangs. 1 mg of vector was incubated with 1 ml of
each restriction enzyme and 2 ml of 106 CutSmart Buffer 4 (New
England Bio Labs) overnight at 37 C˚, samples were then heated to 65 C˚
for 15 min to deactivate enzymes prior to electrophoresis. The linearized
vector underwent gel electrophoresis on a 1% agarose gel and was then
extracted using the Qiagen gel extraction and purification kit. Prior to
ligation with the linearized vector, complementary oligonucleotides were
annealed using Oligo Annealing Buffer (Promega) following the
manufacturer’s instructions. 4 ng of annealed oligonucleotides were
incubated with 50 ng of linearized vector, 2 ml of T4 DNA ligase (New
England BioLabs) and 1 ml of 106T4 DNA ligase buffer (New England
BioLabs) at 4 C˚ overnight. Following ligation the vector, which contains
an ampicillin resistance gene, was transformed into XL-10 Gold Ultra
competent cells (Aligent Technologies) using heat shock as per the
manufacturer’s instructions. Cells were then plated onto ampicillin-
containing agar plates and incubated at 37 C˚ overnight. Colonies were
selected and grown overnight in LB medium containing ampicillin at
37 C˚ and the vector was purified using the Qiagen mini prep kit
(Thermoscientific). Not1 digestion was performed to confirm successful
ligation of the IGF1R and scrambled 39UTR binding sites.
Luciferase reporter assay
Following successful ligation, vectors (50 ng) containing miR-145, or
IGF1R 39UTR sites and pSV-b-Galactosidase Control Vector (100 ng;
Promega) were transfected into Ishikawa cells alone or in combination with
miR-145 or non-targeting miR mimics (100 nM) using DharmaFECT2 as
described above. Untreated and mock-transfected samples and the pmiR-
GLO vector were included as controls. 24 h after transfection cells were
washed twice in PBS and lysed with passive lysis buffer (Promega). Levels
of Firefly luciferase were read using the Orion L Microplate Luminometer
(Titertek) using the luciferase reporter assay (Promega) according to the
manufacturer’s instructions. Levels of b-galactosidase were measured using
the mammalian b-galactosidase assay kit (Pierce, Thermoscientific). Firefly
luciferase was normalized to b-galactosidase in each sample to control for
transfection efficiency.
miR-binding site target protector
Target protectors (purchased from Qiagen) were designed to correspond
to the region of the IGF1R 39UTR (3804–3810 bp) to which miR-145 is
predicted to bind (59-TACCTACCGGTTTCCACAACTGGATTTCT-
ACAGATCATTC-39, where the underlined region represents the seed
sequence). BLAST analysis demonstrated that the target protector did not
have any homology to any mammalian genes, other than IGF1R. The
target protector is therefore specific and allows effective blocking of
miR-145–IGF1R interaction without influencing binding of miR-145 to
its other targets (Stanton and Giraldez, 2011). Effects of miR-145 altered
in the presence of the target protector, are thus attributable to interaction
between miR-145 and IGF1R. A scrambled target protector was designed
as a control (sequence, 59-TACCTACCGGTTTCCACAAAAGGAT-
TTCTACAGATCATTC-39, D3804–3810 bp). Ishikawa cells were
transfected with scrambled or IGF1R target protectors (100 nM)
individually or in combination with miR-145 or non-targeting mimics
(50 nM). 48 h later, IGF1 or BSA-coated beads were added to the cells
and 24–48 h later the ability of miR-145 to influence IGF1R expression
and bead attachment were assessed.
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